Clinical Trials
3 trialsNCT04619433 2025-09-23
A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Terminated
NCT05849246 2024-08-20
The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2 Terminated
NCT05318443 2023-12-27
A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer
Shanghai Institute Of Biological Products
Phase 3 Completed